In a retrospective cohort study, sorafenib combined with Fufang Banmao capsules, a type of TMP including C. aromatica and S. barbata, was found to decrease AFP levels in HCC patients [75]. The gene discussed is AFP; the disease is hepatocellular carcinoma.